ROTHBLATT MARTINE A, CHAIR, CEO, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 1772.000000 shares for an estimated $951265.95. Reported holdings after the transaction were 4687.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
Chairperson & CEO
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will c…
This transaction was executed in multiple trades at prices ranging from $531.94 to $532.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $532.94 to $532.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $534.42 to $535.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $535.45 to $536.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $536.45 to $537.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $537.47 to $538.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $538.48 to $539.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $539.48 to $540.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $540.73 to $541.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $541.86 to $542.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $542.88 to $543.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
This transaction was executed in multiple trades at prices ranging from $543.90 to $544.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
0 other filings
0 recent txs